These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 9850071

  • 1. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
    Keshelava N, Seeger RC, Groshen S, Reynolds CP.
    Cancer Res; 1998 Dec 01; 58(23):5396-405. PubMed ID: 9850071
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
    Kotchetkov R, Driever PH, Cinatl J, Michaelis M, Karaskova J, Blaheta R, Squire JA, Von Deimling A, Moog J, Cinatl J.
    Int J Oncol; 2005 Oct 01; 27(4):1029-37. PubMed ID: 16142320
    [Abstract] [Full Text] [Related]

  • 10. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide.
    Yokomizo A, Ono M, Nanri H, Makino Y, Ohga T, Wada M, Okamoto T, Yodoi J, Kuwano M, Kohno K.
    Cancer Res; 1995 Oct 01; 55(19):4293-6. PubMed ID: 7671238
    [Abstract] [Full Text] [Related]

  • 11. Establishment of an in vitro model for cisplatin resistance in human neuroblastoma cell lines.
    Ireland CM, Pittman SM, Jones SL, Harnett PR.
    Anticancer Res; 1994 Oct 01; 14(6B):2397-403. PubMed ID: 7872659
    [Abstract] [Full Text] [Related]

  • 12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 01; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 13. Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase.
    Deng HB, Adikari M, Parekh HK, Simpkins H.
    Cancer Chemother Pharmacol; 2004 Oct 01; 54(4):301-7. PubMed ID: 15138708
    [Abstract] [Full Text] [Related]

  • 14. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
    Ho R, Eggert A, Hishiki T, Minturn JE, Ikegaki N, Foster P, Camoratto AM, Evans AE, Brodeur GM.
    Cancer Res; 2002 Nov 15; 62(22):6462-6. PubMed ID: 12438236
    [Abstract] [Full Text] [Related]

  • 15. Analysis of microsatellite instability in acquired drug-resistance human tumor cell lines.
    Picard SF, Franco N, Sergent C, Chauffert B, Lizard-Nacol S.
    Oncol Rep; 2002 Nov 15; 9(5):971-6. PubMed ID: 12168057
    [Abstract] [Full Text] [Related]

  • 16. In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells.
    Kavallaris M, Gardaneh M, Cheung B, Camacho ML, Hocker JE, Norris MD, Haber M, Marshall GM.
    Anticancer Res; 1998 Nov 15; 18(3A):1793-7. PubMed ID: 9673406
    [Abstract] [Full Text] [Related]

  • 17. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
    Thomadaki H, Scorilas A.
    Ann N Y Acad Sci; 2007 Jan 15; 1095():35-44. PubMed ID: 17404015
    [Abstract] [Full Text] [Related]

  • 18. Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines.
    Keshelava N, Groshen S, Reynolds CP.
    Cancer Chemother Pharmacol; 2000 Jan 15; 45(1):1-8. PubMed ID: 10647494
    [Abstract] [Full Text] [Related]

  • 19. Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.
    Keshelava N, Zuo JJ, Chen P, Waidyaratne SN, Luna MC, Gomer CJ, Triche TJ, Reynolds CP.
    Cancer Res; 2001 Aug 15; 61(16):6185-93. PubMed ID: 11507071
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.